FI81093C - NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. - Google Patents

NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. Download PDF

Info

Publication number
FI81093C
FI81093C FI882241A FI882241A FI81093C FI 81093 C FI81093 C FI 81093C FI 882241 A FI882241 A FI 882241A FI 882241 A FI882241 A FI 882241A FI 81093 C FI81093 C FI 81093C
Authority
FI
Finland
Prior art keywords
inden
dihydro
imidazole derivatives
nya
oxi
Prior art date
Application number
FI882241A
Other languages
Finnish (fi)
Swedish (sv)
Other versions
FI882241A (en
FI882241A0 (en
FI81093B (en
Inventor
Arto Johannes Karjalainen
Raimo Einari Virtanen
Arja Leena Karjalainen
Kauko Oiva Antero Kurkela
Original Assignee
Farmos Oy
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB08429578A external-priority patent/GB2167408B/en
Application filed by Farmos Oy filed Critical Farmos Oy
Publication of FI882241A publication Critical patent/FI882241A/en
Publication of FI882241A0 publication Critical patent/FI882241A0/en
Application granted granted Critical
Publication of FI81093B publication Critical patent/FI81093B/en
Publication of FI81093C publication Critical patent/FI81093C/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Description

8109381093

Uusia välituotteina käyttökelpoisia 4(5)-(2,3-dihydro-l-oksi-lH-inden-2-yyli)-imidatsolijohdannaisia - Nya som raellanprodukter användbara 4(5)-(2,3-dihydro-l-oxi-lH-inden-2-yl)-imidazolderivatNew 4 (5) - (2,3-dihydro-1-oxy-1H-inden-2-yl) -imidazole derivatives useful as intermediates - Nya som raellanprodukter användbara 4 (5) - (2,3-dihydro-1-oxy- H-inden-2-yl) -imidazolderivat

Jakamalla erotettu hakemuksesta 854335 - Avdelad frän ansökan 854335 Tämä keksintö koskee uusia välituotteita terapeuttisesti arvokkaiden 4(5)-substituoitujen imidatsolijohdannaisten sekä niiden myrkyttömien suolojen valmistuksessa.This invention relates to novel intermediates in the preparation of therapeutically valuable 4 (5) -substituted imidazole derivatives and their non-toxic salts.

Kantahakemuksen FI 854335 mukaiset imidatsolijohdannaiset ovat uusia tehokkaita ja selektiivisiä a2-reseptorianta-gonisteja joiden yleinen kaava on r.3 ?2 R1 r4 ά jossa X on -CH2- , -CH2CH2- tai -O-, on H tai 1-4 hiiliatomia sisältävä alempi alkyyliryhmä, R2 on H, CH3, CH2CH3, OCH3 tai OH, R3 on H, CH3, CH2CH3, OCH3 tai Hai, R4 on H, CH3, CH2CH3, OCH3 tai Hai ja Hai on halogeeni.The imidazole derivatives according to the basic application FI 854335 are new potent and selective α2-receptor antagonists of the general formula r.3? 2 R1 r4 ά wherein X is -CH2-, -CH2CH2- or -O-, is H or contains 1-4 carbon atoms. lower alkyl, R 2 is H, CH 3, CH 2 CH 3, OCH 3 or OH, R 3 is H, CH 3, CH 2 CH 3, OCH 3 or Hal, R 4 is H, CH 3, CH 2 CH 3, OCH 3 or Hal and Hal is halogen.

Kaavan (I) mukaiset yhdisteet, joissa R2 on H tai OH ja XCompounds of formula (I) wherein R 2 is H or OH and X is

on -CH2-, voidaan esimerkiksi valmistaa seuraavalla menetelmällä: 2 81093 <*3 j? »1 «3 R1 0 'V-v. // halogenointi S^' y\ / H-C-NH2 R4 0 R4 0 R3 0 RX R3 OH Rl 0./\ / NaBH4 X. —V // "<lT> ./ ^-x I!is -CH2-, can be prepared, for example, by the following method: 2 81093 <* 3 j? »1« 3 R1 0 'V-v. // halogenation S ^ 'y \ / H-C-NH2 R4 0 R4 0 R3 0 RX R3 OH R10 0 ./ \ / NaBH4 X. —V // "<lT> ./ ^ -x I!

H AH A

γβ H2, Pd/C H2 Pd/C, }β ' /γβ H2, Pd / C H2 Pd / C,} β '/

R3 M XR3 M X

.//r>κ IL/.//r>κ IL /

AA

Välituotteet, joiden kaava on R3 0 Ri ϊι>^τ> R4''^ -nIntermediates of formula R3 0 Ri ϊι> ^ τ> R4 '' ^ -n

HB

jossa R^t R3 ja R4 merkitsevät samaa kuin yllä, ovat uusia.wherein R 1, R 3 and R 4 are as defined above are new.

Esimerkeissä, joissa on esitetty ^-H-NMR-spektrometriset siirtymät, NMR-spektrit on otettu Bruker WB 80 I)S-laitteella sisäistä tetrametyylisilaanistandardia käyttäen, jostaIn the examples showing 1 H-NMR spectrometric shifts, the NMR spectra were taken on a Bruker WB 80 I) S instrument using an internal tetramethylsilane standard from which

IIII

3 81093 esitetyt kemialliset siirtymät (6, ppm) on taulukoitu. Kirjaimin s, d, t ja m on ilmoitettu, onko kysymyksessä singletti, dubletti, tripletti vai multipletti. Samaan yhteyteen on niin ikään merkitty vetyatomien lukumäärä.The chemical shifts (6, ppm) shown in 3,81093 are tabulated. The letters s, d, t and m indicate whether it is a singlet, a doublet, a triplet or a multiplet. The number of hydrogen atoms is also indicated in the same context.

Esimerkki 1 4(5)-(2,3-Dihydro-2-etyyli-l-hydroksi-lH-inden-2-yyli)imi-datsoli a) 4(5)-(2,3-Dihydro-2-etyyli-l-okso-lH-inden-2-yyli)imi-datsoli 2-Asetyyli-l-indanoni (Liebigs Ann. Chem. 347 (1906) 112) alkyloidaan etyylibromidilla asetonissa natriumkarbonaatin läsnäollessa, jolloin saadaan 2-asetyyli-2-etyyli-l-inda-nonia. 2.2 g 2-asetyyli-2-etyyli-l-indanonia liuotetaan 10 ml:aan metanolia. Lisätään nopeasti bromi (1.60 g) metanoliin (2 ml) liuotettuna 40-50°C:ssa. Reaktio seurataan kaasukromatograafisesti. Reaktion mentyä lisätään vettä. Tuote uutetaan tolueeniin, ja tolueeniliuos pestään 10% Na2C03-liuoksella ja lopuksi vedellä. Tolueeniliuos kuivataan ja haihdutetaan. 2-bromi-l-(2-etyyli-2,3-dihydro- l-okso-lH-inden-2-yyli)etanonin (2.2 g) ja formamidin (20 ml) seosta kuumennetaan l30-140°C:ssa yksi vuorokausi.Example 1 4 (5) - (2,3-Dihydro-2-ethyl-1-hydroxy-1H-inden-2-yl) imidazole a) 4 (5) - (2,3-Dihydro-2-ethyl -1-Oxo-1H-inden-2-yl) imidazole 2-Acetyl-1-indanone (Liebigs Ann. Chem. 347 (1906) 112) is alkylated with ethyl bromide in acetone in the presence of sodium carbonate to give 2-acetyl-2-ethyl -L-inda-fluoroacetophenone. 2.2 g of 2-acetyl-2-ethyl-1-indanone are dissolved in 10 ml of methanol. Bromine (1.60 g) dissolved in methanol (2 ml) is rapidly added at 40-50 ° C. The reaction is monitored by gas chromatography. After the reaction, water is added. The product is extracted into toluene and the toluene solution is washed with 10% Na2CO3 solution and finally with water. The toluene solution is dried and evaporated. A mixture of 2-bromo-1- (2-ethyl-2,3-dihydro-1-oxo-1H-inden-2-yl) ethanone (2.2 g) and formamide (20 ml) is heated at 130-140 ° C for one day.

Seos jäähdytetään, kaadetaan veteen ja tehdään happamaksi suolahapolla. Hapan liuos pestään tolueenilla. Sen jälkeen vesiliuos tehdään emäksiseksi ja tuote uutetaan metyleenikloridiin. Metyleenikloridiliuos pestään vedellä, kuivataan ja haihdutetaan kuiviin. Tuote kiteytetään emäksenä etyyliasetaatista, sp. 126-7°C.The mixture is cooled, poured into water and acidified with hydrochloric acid. The acidic solution is washed with toluene. The aqueous solution is then basified and the product is extracted into methylene chloride. The methylene chloride solution is washed with water, dried and evaporated to dryness. The product is crystallized as a base from ethyl acetate, m.p. 126-7 ° C.

b) 4(5)-(2,3-Dihydro-2-etyyli-l-hydroksi-lH-inden-2-yyli)-imidatsolib) 4- (S) - (2,3-Dihydro-2-ethyl-1-hydroxy-1H-inden-2-yl) -imidazole

Okso-indeeni-imidatsolin (vaihe a) karbonyyliryhmä pelkistetään NaBH^sllä etanolissa alkoholiryhmäksi. Tuote on 4 81093 cis-transstereoisomeerien seos, ja sen puhdistus suoritetaan nestekromatograafisesti.The carbonyl group of the oxoindene imidazole (step a) is reduced with NaBH 4 in ethanol to the alcohol group. The product is a mixture of 4,81093 cis-transstereoisomers and is purified by liquid chromatography.

cis-isomeeri hydrokloridina (s.p. 184-185°C): !h NMR (80 MHz, MeOH-d4): 6 0.73 (3H t), 1.86 (2H, m), 3.36 (2H, m), 3.61 (3H, s), 5.15 (1H, s), 7.06 (1H, d), 7.2-7.4 (4H, m), 8.69 (1H, d) trans-isomeeri hydrokloridinas *H NMR (80 MHz, MeOH-d4): 8 0.80 (3H, t), 1.84 (2H, m), 3.15 (2H, m), 3.24 (3H, s), 5.15 (1H, s), 6.87 (1H, d), 7.2-7.4 (4H, m), 8.54 (1H, d)cis-isomer as hydrochloride (mp 184-185 ° C): 1 H NMR (80 MHz, MeOH-d 4): δ 0.73 (3H t), 1.86 (2H, m), 3.36 (2H, m), 3.61 (3H, s), 5.15 (1H, s), 7.06 (1H, d), 7.2-7.4 (4H, m), 8.69 (1H, d) trans-isomer in hydrochloride 1 H NMR (80 MHz, MeOH-d 4): δ 0.80 (3H, t), 1.84 (2H, m), 3.15 (2H, m), 3.24 (3H, s), 5.15 (1H, s), 6.87 (1H, d), 7.2-7.4 (4H, m), 8.54 (1 H, d)

Esimerkki 2 4(5)-(2,3-Dihydro-2-etyyli-lH-inden-2-yyli)-imidatsoliExample 2 4 (S) - (2,3-Dihydro-2-ethyl-1H-inden-2-yl) -imidazole

Esimerkin 1 vaiheen a) mukaisesti valmistettu okso-johdannainen tai vaiheen b) mukaisesti valmistettu hydroksi-johdannainen vedytetään 2N HClsssä lämpötilassa 70°C käyttäen 10 % Pd/C katalyyttinä. Kun vedyn kulutus loppuu, reaktioseos suodatetaan ja tehdään alkaaliseksi. Tuote uutetaan metyleenikloridilla, joka pestään vedellä, kuivataan ja haihdutetaan. Lopputuotteesta, joka on tuotteen emäsmuoto, tehdään hydrokloridi etyyliasetaatissa kuivalla HC1:llä. S.p. 2ll-215°C.The oxo derivative prepared according to step a) of Example 1 or the hydroxy derivative prepared according to step b) is hydrogenated in 2N HCl at 70 ° C using 10% Pd / C as a catalyst. When the consumption of hydrogen ceases, the reaction mixture is filtered and made alkaline. The product is extracted with methylene chloride, which is washed with water, dried and evaporated. The final product, which is the base form of the product, is converted to the hydrochloride in ethyl acetate with dry HCl. Mp 2LL-215 ° C.

ilil

Claims (1)

5 81093 Patenttivaatimus 4(5)-(2,3-dihydro-l-oksi-lH-inden-2-yyli)imidatsoli johdannainen, jonka kaava on Ro O Ri H jossa R^ on H tai 1-4 hiiliatomia sisältävä alempi alkyyli-ryhmä ja R3 ja R4, jotka voivat olla samanlaisia tai erilaisia, ovat H, -CH3, -CH2CH3, -OCH3 tai halogeeni. 6 81093 Ett 4(5)-(2,3-dihydro-l-oxi-lH-inden-2-yl)imidazolderivat, vars formel är r3v ^ \ R4 ^ ^ |' H där R^ är H eller en lägre alkylgrupp med 1-4 kolatomer och R3 och R4, som kan vara sairana eller olika, är H, -CH3, -CH2CH3, -OCH3 eller halogen. II5,81093 Claim 4 (5) - (2,3-dihydro-1-oxy-1H-inden-2-yl) imidazole derivative of the formula Ro O R 1 H wherein R 1 is H or lower alkyl having 1 to 4 carbon atoms the group and R 3 and R 4, which may be the same or different, are H, -CH 3, -CH 2 CH 3, -OCH 3 or halogen. 6,81093 to 4 (S) - (2,3-dihydro-1-oxy-1H-inden-2-yl) imidazole derivatives, especially formula H is R 1 or H or an alkyl group containing 1-4 cholaters and R 3 and R 4, which may be sickly or ol, H, -CH 3, -CH 2 CH 3, -OCH 3 or halogen. II
FI882241A 1984-11-23 1988-05-13 NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES. FI81093C (en)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB8429578 1984-11-23
GB08429578A GB2167408B (en) 1984-11-23 1984-11-23 Substituted imidazole derivatives and their preparation and use
FI854335A FI80264C (en) 1984-11-23 1985-11-05 FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA IMIDAZOLDERIVAT, SOM AER SUBSTITUERADE MED EN BISYKLISK GRUPP I 4 (5) -STAELLNING.
FI854335 1985-11-05

Publications (4)

Publication Number Publication Date
FI882241A FI882241A (en) 1988-05-13
FI882241A0 FI882241A0 (en) 1988-05-13
FI81093B FI81093B (en) 1990-05-31
FI81093C true FI81093C (en) 1990-09-10

Family

ID=26157830

Family Applications (2)

Application Number Title Priority Date Filing Date
FI882241A FI81093C (en) 1984-11-23 1988-05-13 NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES.
FI882242A FI80880C (en) 1984-11-23 1988-05-13 New 4 (5) -substituted imidazole derivatives useful as intermediates

Family Applications After (1)

Application Number Title Priority Date Filing Date
FI882242A FI80880C (en) 1984-11-23 1988-05-13 New 4 (5) -substituted imidazole derivatives useful as intermediates

Country Status (1)

Country Link
FI (2) FI81093C (en)

Also Published As

Publication number Publication date
FI80880C (en) 1990-08-10
FI882241A (en) 1988-05-13
FI882242A0 (en) 1988-05-13
FI882241A0 (en) 1988-05-13
FI80880B (en) 1990-04-30
FI882242A (en) 1988-05-13
FI81093B (en) 1990-05-31

Similar Documents

Publication Publication Date Title
US4113869A (en) Tetrahydroisoquinoline basic ethers and pharmaceutical compositions and methods employing them
FI63229C (en) FREQUENCY REFRIGERATION OF ANALYTICAL NETWORK RACEMISKT ELLER DIASTEREOMERA AND OPTICAL ACTIVE 2-TETRAHYDROFURFURYL-5,9 BETA-DIMETHYL-6,7-BENZENORORFAN OCH DERAS SYRAADDITION
IE62244B1 (en) 4H-1-benzopyran-4-one derivatives, a process for their preparation and their use as medicaments
DK158307B (en) METHOD OF ANALOGUE FOR THE PREPARATION OF 4- (PHENYLALKYL) IMIDAZOLD DERIVATIVES OR PHARMACEUTICAL ACCEPTABLE ACID ADDITION SALTS THEREOF
US4665188A (en) Certain [(1-imidazolyl)-lower-alkylene]-tetrahydronaphthalenecarboxylic acids or corresponding idan-carboxylic acids which are thromboxane A2
CZ284256B6 (en) Novel process for preparing formoterol and related compounds
FI86175B (en) FOERFARANDE FOER FRAMSTAELLNING AV NYA TERAPEUTISKT ANVAENDBARA FENOLDERIVAT.
EP0130833A1 (en) Coumarin compounds, their preparation, and pharmaceutical compositions containing them
FI92824C (en) Process for the preparation of therapeutically useful chromane derivatives
US4336268A (en) Cyclohexene derivative analgesics
FI81093C (en) NYA SOM MELLANPRODUKTER ANVAENDBARA 4 (5) - (2,3-DIHYDRO-1-OXI-1H-INDEN-2-YL) -IMIDAZOLE DERIVATIVES.
Lee et al. Chiral acetylenic sulfoxide in alkaloid synthesis. Total synthesis of (R)-(+)-carnegine.
US4181666A (en) Process for making furanones
FI67851C (en) FAR OIL FRAMSTAELLNING AV NYA DOPAMINAGONISTISKT VERKANDE BENSO (4,5) PYRANO (2,3C) PYRROLDERIVAT
FI79100C (en) Isoquinoline derivatives and process for their preparation.
US4411907A (en) Antiinflammatory 3H-naphtho(1,2-d)imidazoles
US4238612A (en) Process for the isomerization of derivatives of 3-vinyl-piperidine
US4751298A (en) Production of 1-(3-hydroxy-propyl)-1,4-diazepane and 1,4-bis(3,4,5-trimethoxy-benzoyloxy)-propyl-diazepane derivatives thereof
US3798225A (en) 3(2h)-isoquinolones
FI61694C (en) FRAMEWORK FOR FRAMSTERING OF SUBSTITUTES WITH A BLOOD TRYCKET WITH A SHORT-BASED SAFETY NETWORK
EP0110496B1 (en) Improvements in keto intermediates, their use and preparation
Cozzi et al. Imidazolyl derivatives of the chroman ring. 1
US4528372A (en) N-Phthalidyl-5-fluorouracils
EP0379935A1 (en) A process for preparing naphthalene derivatives
US4015006A (en) 3(2H)-Isoquinolones therapeutic process

Legal Events

Date Code Title Description
MM Patent lapsed
MM Patent lapsed

Owner name: FARMOS-YHTYMAE OY